These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

427 related items for PubMed ID: 2932513

  • 1. Serial changes in humoral and cellular immunity induced by prostaglandin E2 treatment of murine immune complex glomerulonephritis.
    McLeish KR, Stelzer GT, Eades DS, Cohen R, Wallace JH.
    J Lab Clin Med; 1985 Nov; 106(5):517-23. PubMed ID: 2932513
    [Abstract] [Full Text] [Related]

  • 2. Suppression of antibody synthesis by prostaglandin E as a mechanism for preventing murine immune complex glomerulonephritis.
    McLeish KR, Gohara AF, Gunning WT.
    Lab Invest; 1982 Aug; 47(2):147-52. PubMed ID: 6213813
    [Abstract] [Full Text] [Related]

  • 3. Separation of a population of human T lymphocytes that bind prostaglandin E2 and exert a suppressor activity.
    Fischer A, Le Deist F, Durandy A, Griscelli C.
    J Immunol; 1985 Feb; 134(2):815-9. PubMed ID: 2856929
    [Abstract] [Full Text] [Related]

  • 4. Interstrain variations in nephritogenicity of heterologous protein in mice.
    Iskandar SS, Jennette JC, Wilkman AS, Becker RL.
    Lab Invest; 1982 Mar; 46(3):344-51. PubMed ID: 6460898
    [Abstract] [Full Text] [Related]

  • 5. Role of prostaglandin E2 in the induction of nonspecific T lymphocyte suppressor activity.
    Fischer A, Durandy A, Griscelli C.
    J Immunol; 1981 Apr; 126(4):1452-5. PubMed ID: 6451647
    [Abstract] [Full Text] [Related]

  • 6. Decreased sensitivity of atopic mononuclear cells to prostaglandin E2 (PGE2) and prostaglandin D2 (PGD2).
    Rocklin RE, Thistle L, Audera C.
    J Immunol; 1985 Sep; 135(3):2033-9. PubMed ID: 3160784
    [Abstract] [Full Text] [Related]

  • 7. Programmed death 1 and its ligands do not limit experimental foreign antigen-induced immune complex glomerulonephritis.
    Ooi JD, Li M, Kourkoutzelos K, Yagita H, Azuma M, Holdsworth SR, Kitching AR.
    Nephrology (Carlton); 2015 Dec; 20(12):892-8. PubMed ID: 26043977
    [Abstract] [Full Text] [Related]

  • 8. Treatment of murine immune complex glomerulonephritis with prostaglandin E2: dose--response of immune complex deposition, antibody synthesis, and glomerular damage.
    McLeish KR, Gohara AF, Stelzer GT, Wallace JH.
    Clin Immunol Immunopathol; 1983 Jan; 26(1):18-23. PubMed ID: 6575881
    [Abstract] [Full Text] [Related]

  • 9. The role of regulatory components from resident T lymphocytes in polyclonal B cell activation.
    Goodman MG, Weigle WO.
    J Cell Biochem; 1982 Jan; 18(4):395-405. PubMed ID: 6211460
    [Abstract] [Full Text] [Related]

  • 10. Regulation of tumor-induced myelopoiesis and the associated immune suppressor cells in mice bearing metastatic Lewis lung carcinoma by prostaglandin E2.
    Young MR, Young ME, Kim K.
    Cancer Res; 1988 Dec 01; 48(23):6826-31. PubMed ID: 2972359
    [Abstract] [Full Text] [Related]

  • 11. Antigen-specific IGG2A production in response to prostaglandin E2, immune complexes, and IFN-gamma.
    Stein SH, Phipps RP.
    J Immunol; 1991 Oct 15; 147(8):2500-6. PubMed ID: 1655892
    [Abstract] [Full Text] [Related]

  • 12. The in vivo regulation of splenic T cell population by the prostaglandin-mediated system.
    Taniguchi K, Koga Y, Kato M, Nomoto K.
    J Clin Lab Immunol; 1984 Aug 15; 14(4):195-203. PubMed ID: 6238169
    [Abstract] [Full Text] [Related]

  • 13. Prostaglandin E1 therapy of murine chronic serum sickness.
    McLeish KR, Gohara AF, Gunning WT, Senitzer D.
    J Lab Clin Med; 1980 Sep 15; 96(3):470-9. PubMed ID: 6995540
    [Abstract] [Full Text] [Related]

  • 14. Prostaglandin E2 inhibits the activation of cloned T cell hybridomas.
    Makoul GT, Robinson DR, Bhalla AK, Glimcher LH.
    J Immunol; 1985 Apr 15; 134(4):2645-50. PubMed ID: 2857750
    [Abstract] [Full Text] [Related]

  • 15. Polyclonal activation of the murine immune system by an antibody to IgD. IV. In vivo activation of B lymphocytes from immune defective CBA/N mice.
    Muul LM, Scher I, Mond JJ, Finkelman FD.
    J Immunol; 1983 Nov 15; 131(5):2226-31. PubMed ID: 6605378
    [Abstract] [Full Text] [Related]

  • 16. Regulation of in vitro cytotoxic T lymphocyte generation. III. Interactions or regulatory T cell subsets in suppressor and target populations.
    Schwartz A, Gershon RK.
    J Mol Cell Immunol; 1984 Nov 15; 1(4):237-52. PubMed ID: 6152894
    [Abstract] [Full Text] [Related]

  • 17. Regulation of human B cell proliferation by prostaglandin E2.
    Thompson PA, Jelinek DF, Lipsky PE.
    J Immunol; 1984 Nov 15; 133(5):2446-53. PubMed ID: 6332851
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms of mouse T lymphocyte-induced suppression of the IgG2ab allotype and T lymphocyte tolerance to IgG2ab.
    Majlessi L, Bordenave G.
    Arch Immunol Ther Exp (Warsz); 2001 Nov 15; 49(6):407-15. PubMed ID: 11814234
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prostaglandin E2 inhibits T cell-dependent Ig secretion by neonatal but not adult lymphocytes.
    Splawski JB, Lipsky PE.
    J Immunol; 1994 Jun 01; 152(11):5259-67. PubMed ID: 7514634
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.